- Home
- LIQT vs IBIO Comparison
LIQT vs IBIO Comparison
Compare LIQT & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LIQT | IBIO |
|---|---|---|
| Founded | 2004 | 2008 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.3M | 16.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LIQT | IBIO |
|---|---|---|
| Price | $1.88 | $1.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $4.20 | ★ $4.50 |
| AVG Volume (30 Days) | 16.3K | ★ 12.9M |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $16,788,295.00 | $500,000.00 |
| Revenue This Year | $34.09 | N/A |
| Revenue Next Year | $18.75 | $11.11 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 10.97 | ★ 185.71 |
| 52 Week Low | $1.34 | $0.56 |
| 52 Week High | $3.35 | $6.89 |
Technical Indicators
Market Signals| Indicator | LIQT | IBIO |
|---|---|---|
| Relative Strength Index (RSI) | 40.45 | 58.19 |
| Support Level | $1.81 | $0.98 |
| Resistance Level | $2.14 | $3.82 |
| Average True Range (ATR) | 0.11 | 0.37 |
| MACD | 0.01 | 0.13 |
| Stochastic Oscillator | 2.47 | 33.80 |
Price Performance
Historical ComparisonAbout LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.